Oral human gammaglobulin (Research Corporation Technologies)

N/A

Report date: 2022/11/25 17:17:16

Base Information

Drug NameOral human gammaglobulin (Research Corporation Technologies)
Drug Alias NameHuman gammaglobulinOralgamIgPO
ClassificationBiologics > Protein drugs > Immunoglobulin
Mechanisms of ActionImmunosuppressants
TargetsNot applicable
Therapy Area/IndicationsAutistic DisorderChild Development Disorders, PervasiveSigns and Symptoms, Digestive +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesResearch Corporation Technologies
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPediamed Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsAutistic DisorderChild Development Disorders, PervasiveSigns and Symptoms, Digestive +[4] 

Other Information

ATC CodeN/A
Related LinksN/A